Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment

W Li, F Li, X Zhang, HK Lin, C Xu - Signal transduction and targeted …, 2021 - nature.com
More and more in-depth studies have revealed that the occurrence and development of
tumors depend on gene mutation and tumor heterogeneity. The most important …

Rational design of peptide-based inhibitors disrupting protein-protein interactions

X Wang, D Ni, Y Liu, S Lu - Frontiers in chemistry, 2021 - frontiersin.org
Protein-protein interactions (PPIs) are well-established as a class of promising drug targets
for their implications in a wide range of biological processes. However, drug development …

Structure-based discovery of SD-36 as a potent, selective, and efficacious PROTAC degrader of STAT3 protein

H Zhou, L Bai, R Xu, Y Zhao, J Chen… - Journal of medicinal …, 2019 - ACS Publications
Signal transducer and activator of transcription 3 (STAT3) is a transcription factor and an
attractive therapeutic target for cancer and other human diseases. Despite 20 years of …

[HTML][HTML] Targeting cullin neddylation for cancer and fibrotic diseases

ZX He, W Yang, D Zengyangzong, G Gao, Q Zhang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Protein neddylation is a post-translational modification, and its best recognized substrates
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …

Protein neddylation and its role in health and diseases

S Zhang, Q Yu, Z Li, Y Zhao, Y Sun - Signal Transduction and Targeted …, 2024 - nature.com
NEDD8 (Neural precursor cell expressed developmentally downregulated protein 8) is an
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …

The next frontier: translational development of ubiquitination, SUMOylation, and NEDDylation in cancer

NE Pellegrino, A Guven, K Gray, P Shah… - International Journal of …, 2022 - mdpi.com
Post-translational modifications of proteins ensure optimized cellular processes, including
proteostasis, regulated signaling, cell survival, and stress adaptation to maintain a balanced …

NEDD8-conjugating enzyme E2s: critical targets for cancer therapy

L Zhou, X Lin, J Zhu, L Zhang, S Chen, H Yang… - Cell Death …, 2023 - nature.com
Abstract NEDD8-conjugating enzymes, E2s, include the well-studied ubiquitin-conjugating
enzyme E2 M (UBE2M) and the poorly characterized ubiquitin-conjugating enzyme E2 F …

Targeting neddylation E2s: a novel therapeutic strategy in cancer

YC Zheng, YJ Guo, B Wang, C Wang… - Journal of Hematology & …, 2021 - Springer
Ubiquitin-conjugating enzyme E2 M (UBE2M) and ubiquitin-conjugating enzyme E2 F
(UBE2F) are the two NEDD8-conjugating enzymes of the neddylation pathway that take part …

[HTML][HTML] Anticancer drug discovery by targeting cullin neddylation

Q Yu, Y Jiang, Y Sun - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Protein neddylation is a post-translational modification which transfers the ubiquitin-like
protein NEDD8 to a lysine residue of the target substrate through a three-step enzymatic …

Discovery of neddylation E2s inhibitors with therapeutic activity

MAA Mamun, Y Liu, YP Geng, YC Zheng, Y Gao… - Oncogenesis, 2023 - nature.com
Neddylation is the writing of monomers or polymers of neural precursor cells expressed
developmentally down-regulated 8 (NEDD8) to substrate. For neddylation to occur, three …